We are live on ! Find out more
IMUX icon

Immunic
IMUX

51 hedge funds and large institutions have $52.1M invested in Immunic in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $344K | Put options by funds: $130K

4% less capital invested

Capital invested by funds: $54.5M → $52.1M (-$2.41M)

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

6% less funds holding

Funds holding: 54 → 51 (-3)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
13
Closed
6
Calls
$344K
Puts
$130K
Net Calls
+$214K
Net Calls Change
-$43K

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$14.3M
2
BCM
Bridgeway Capital Management
Texas
+$555K
3
BFA
BlackRock Fund Advisors
California
+$444K
4
SEI Investments
SEI Investments
Pennsylvania
+$323K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$69.1K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.45M
2
CS
Credit Suisse
Switzerland
-$91.3K
3
ARTA
A.R.T. Advisors
New York
-$84K
4
VKH
Virtu KCG Holdings
New York
-$78K
5
SG Americas Securities
SG Americas Securities
New York
-$76K

IMUX Hedge Fund Activity: Q3 2016 in Review

51 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2016, worth a combined $52.1M — down 4.4% from $54.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMUX and 5 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 12 added.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $14.3M. The largest seller was Fidelity Investments, cutting an estimated $3.45M.

  • 51 institutional investors held Immunic (IMUX) as of Q3 2016, down from 54 in Q2 2016.
  • Funds reported $52.1M of Immunic stock for Q3 2016, down 4.4% quarter-over-quarter.
  • 5 funds opened new Immunic positions in Q3 2016 and 6 closed out, a net change of -1 holder.
  • The largest Immunic buyer in Q3 2016 was Victory Capital Management, an estimated $14.3M added.
  • The largest Immunic seller in Q3 2016 was Fidelity Investments, an estimated $3.45M sold.

Based on aggregated 13F filings for Q3 2016.